ライフサイエンスコーパス: odds ratio

1 RT (25% of responders, 47% of nonresponders; odds ratio 0.3 [0.12-0.76]; P=0.01).

2 infection than adults 15 to 64 years of age (odds ratio 0.34, 95% confidence interval 0.24 to 0.49),

3 risk for perioperative wound complications (Odds Ratio 0.400 [95% confidence interval 0.168, 0.954],

4 ezomib and dexamethasone (70 [34%] patients; odds ratio 0.50 [95% CI 0.32-0.79], p=0.0013).

5 among individuals aged 15-24 years (adjusted odds ratio 0.55, 95% CI 0.45-0.68) and mobile individual

6 monary embolism (52%) died at ICU discharge (odds ratio 0.79 [0.24-3.26]; p = 0.99).

7 t associated with anastomotic leak (adjusted odds ratio 0.85, 95% CI 0.58-1.21, P = 0.382).

8 ere found to be less likely to visit the ED (odds ratio 0.88 [95% CI 0.80 to 0.97], p = 0.012).

9 rval 0.62-1.58) or acute rejection (adjusted odds ratio 0.89, 95% confidence interval 0.40-1.97) comp

10 ent only, regardless of wound protector use (odds ratio = 0.69-0.70, P < 0.001).

11 n association between BCG and LTBI (adjusted odds ratio = 0.70; 95% confidence interval, .56-.87; P =

12 imilar for affected and unaffected sibships (odds ratio = 0.8, 95% CI = 0.5-1.2) and was explained by

13 d is associated with a longer hospital stay (odds ratio = 0.92; P < .001).

14 15 AU/mL was associated with 90% lower odds (odds ratio, 0.09; P = .005) of A/H1N1 illness.

15 e presence of an endotracheal tube (adjusted odds ratio, 0.13; 95% CI, 0.1-0.2) and urinary catheter

16 lower odds after adjustment for covariates (odds ratio, 0.26 for group 2 vs. group 1; 95% confidence

17 ssociated with reduced risk for retreatment (odds ratio, 0.26; 95% confidence interval, 0.04-0.99; P

18 genation (< 66 hr: odds ratio, 1; 66-128 hr: odds ratio, 0.281; 95% CI, 0.101-0.777; p = 0.014; 128-2

19 CI, 0.1-0.2) and urinary catheter (adjusted odds ratio, 0.28; 95% CI, 0.1-0.6).

20 71-10.4], P=0.002), coronary artery disease (odds ratio, 0.35 [95% CI, 0.16-0.79], P=0.01), left atri

21 rge to home was associated with younger age (odds ratio, 0.36; 95% CI, 0.34-0.39 for age 80-105 vs ag

22 oximately 2.5-times lower odds of infection (odds ratio, 0.39 for group 2 vs. group 1; 95% confidence

23 95% CI, 0.101-0.777; p = 0.014; 128-232 hr: odds ratio, 0.474; 95% CI, 0.191-1.174; p = 0.107; and >

24 controlling for clinical factors, rs3853445 (odds ratio, 0.47; 95% CI, 0.30-0.73; p = 0.001) and rs12

25 , 0.16-0.79], P=0.01), left atrial diameter (odds ratio, 0.52 per 1 cm increase [95% CI, 0.30-0.90],

26 significantly less reported health care use (odds ratio, 0.63; 95% CI, 0.47-0.85; P < .01) and were s

27 symptoms between ages 3 to 8 years (adjusted odds ratio, 0.73; 95% confidence interval, 0.57-0.93).

28 risk of alcohol-related cirrhosis (adjusted odds ratio, 0.76; P=.0027); conversely, the minor C alle

29 tly less likely to have poor asthma control (odds ratio, 0.80; 95% CI, 0.69-0.94; P < .01).

30 elay and was lowest at 48-72 hours (adjusted odds ratio, 0.87; 95% confidence interval, 0.79-0.94).

31 er odds of an FN finding of advanced cancer (odds ratio, 0.9 [95% CI: 0.5, 1.5]).

32 159 (24%) in the talc slurry group (adjusted odds ratio, 0.91 [95% CI, 0.54-1.55]; P = .74; differenc

33 P<0.001), contrary to PCI of stable lesions (odds ratio, 0.92 [95% CI.

34 ased risk-adjusted acute hospital mortality (odds ratio, 0.94; 95% CI, 0.90-0.99; p = 0.01), whereas

35 cant decrease in day 30 mortality over time (odds ratio, 0.96; 95% CI, 0.93-0.98; p = 0.001).

36 aphics, risk factors, and year of admission (odds ratio, 0.97; 95% confidence interval, .85-1.12; P =

37 days controlling for other factors (adjusted odds ratio: 0.41; 95% confidence interval, .22 - .77).

38 d 58.47% drinking days (heavy drinking days: odds ratio=0.14, 95% CI=0.058, 0.333; drinking days: odd

39 io=0.14, 95% CI=0.058, 0.333; drinking days: odds ratio=0.265, 95% CI=0.146, 0.481).

40 adopting Nursing License Compact membership (Odds Ratio=0.51; 95% Confidence Interval: 0.32-0.80) was

41 dates were most likely to receive a request: odds ratio 1.39, 95% CI [1.08-1.78], P = 0.01.

42 rs of age are more susceptible to infection (odds ratio 1.47, 95% confidence interval 1.12 to 1.92).

43 mcr-1 gene detection correlated positively (odds ratio 1.71; 95% CI 0.96-3.06; p = 0.068) with the u

44 with glycosylated hemoglobin less than 6.5% (odds ratio = 1.08 per 0.1 stress hyperglycemia ratio inc

45 greater than or equal to 6.5% (48 mmol/mol) (odds ratio = 1.08 per 0.1 stress hyperglycemia ratio inc

46 e 8 (lead SNP rs17052966, p = 4.53 x 10(-9), odds ratio = 1.28, se = 0.04).

47 polymorphism (SNP) at 16p12.3 is rs78193826 (odds ratio = 1.46, 95% confidence interval = 1.29-1.66,

48 No difference in mortality was observed (odds ratio, 1.04; 95% CI, 0.80-1.35).

49 rain and increased acute hospital mortality (odds ratio, 1.04; 95% CI, 1.00-1.10; p = 0.07).

50 8% with valproate v 17.2% without valproate; odds ratio, 1.06; 95% CI, 0.51 to 2.21; one-sided P = .4

51 5% CI, 0.191-1.174; p = 0.107; and > 232 hr: odds ratio, 1.084; 95% CI, 0.429-2.737; p = 0.864; overa

52 probability of a volumetric RECIST response (odds ratio, 1.09, 1.09, and 1.10, respectively).

53 elivering large-for-gestational-age infants (odds ratio, 1.15; 95% confidence interval, 1.06, 1.24);

54 tality (28.2% vs. 19.7%; P < 0.001; adjusted odds ratio, 1.17 [95% CI, 1.02-1.33]; primary propensity

55 ]; primary propensity-matched model adjusted odds ratio, 1.19 [95% CI, 1.02-1.40]).Conclusions: Publi

56 tly attenuated when adjusting for a CAD PRS (odds ratio, 1.26 [95% CI, 1.16-1.38] for LDL-C and 1.24

57 le generalized estimating analysis (adjusted odds ratio, 1.27 [95% CI, 1.19-1.35]).

58 risk of alcohol-related cirrhosis (adjusted odds ratio, 1.30; P=.020).

59 % CI, 1.23-1.47) and diabetic complications (odds ratio, 1.35; 95% CI, 1.2-1.51), and admission after

60 of 0 vs 2), diagnoses of overdose/poisoning (odds ratio, 1.35; 95% CI, 1.23-1.47) and diabetic compli

61 ndependently associated with CHIP (all CHIP: odds ratio, 1.36 [95% 1.10-1.68]; P=0.004; CHIP with var

62 h FLG mutations compared with those without (odds ratio, 1.36; 95% CI, 1.02-1.80; P = .035).

63 t Sequential Organ Failure Assessment-first (odds ratio, 1.39; 95% CI, 1.20-1.61).

64 04; CHIP with variant allele frequency >0.1: odds ratio, 1.40 [95% CI, 1.10-1.79]; P=0.007).

65 , 2.52-4.19; p < 0.01) and vasopressors use (odds ratio, 1.42; 95% CI, 1.10-1.83; p < 0.01) were inde

66 ed with coronary artery disease-related SCD (odds ratio, 1.44 [95% CI, 1.24-1.67]; P<0.001).

67 similar, yet nonsignificant trend (adjusted odds ratio, 1.44; 95% confidence interval, .81-2.56).

68 y (odds ratio, 1.79 [1.75-1.82]) or at home (odds ratio, 1.55 [1.53-1.56]) versus a medical facility

69 he placebo group (19% and 14%, respectively; odds ratio, 1.56; 95% CI, 0.78 to 3.10; P = 0.20).

70 le of children at high risk of liver injury (odds ratio, 1.56; 95% confidence interval, 1.21-1.92) th

71 ation, favored D-RVd vs RVd (42.4% vs 32.0%; odds ratio, 1.57; 95% confidence interval, 0.87-2.82; 1-

72 ber of vessels injured per patient (adjusted odds ratio, 1.6 per one-vessel increase [95% CI: 1.3, 2.

73 d with the usual care group (30% versus 21%; odds ratio, 1.60 [95% CI, 1.07-2.42]; P=0.03).

74 and/or brain death, as a composite outcome (odds ratio, 1.63; 95% CI, 1.03-2.59; p = 0.04), independ

75 5% CI, 0.30-0.73; p = 0.001) and rs12415501 (odds ratio, 1.72; 95% CI, 1.27-2.59; p = 0.01) remained

76 e 80-105 vs age 18-39), fewer comorbidities (odds ratio, 1.74; 95% CI, 1.63-1.85 for Charlson comorbi

77 The odds of dying in a hospice facility (odds ratio, 1.79 [1.75-1.82]) or at home (odds ratio, 1.

78 associated with a prolonged length of stay (odds ratio, 1.85; 1.49-2.29) and, after adjustment for S

79 40 was associated with the primary endpoint (odds ratio, 1.94; 95% CI, 1.18-3.18; p = 0.009) and resp

80 ently associated with the risk of carcinoma (odds ratio, 1.97; 95% confidence interval, 1.14-3.41), s

81 xtracorporeal membrane oxygenation (< 66 hr: odds ratio, 1; 66-128 hr: odds ratio, 0.281; 95% CI, 0.1

82 in-hospital mortality remained significant (odds ratios, 1.29 and 1.26, respectively).

83 lure was not different between the 2 groups (odds ratio: 1.18; 95% confidence interval: 0.99 to 1.41;

84 1), and mortality (40.0% vs. 24.9%; adjusted odds ratio: 1.88; 95% confidence interval: 1.27 to 2.78;

85 h VI had significantly higher odds of falls (Odds Ratio:1.47; p = 0.043).

86 elihood of mental health treatment (adjusted odds ratio=1.01, 95% CI=0.98, 1.03).

87 he lowest use of benzodiazepines or Z-drugs (odds ratio=1.08, 95% CI=1.01, 1.15) compared with no lif

88 maly (N=23,300, k=11; prevalence=4.1%, k=11; odds ratio=1.81, 95% CI=1.35-2.41; number needed to harm

89 es (N=1,348,475, k=12; prevalence=1.2%, k=9; odds ratio=1.86, 95% CI=1.16-2.96; NNH=71, 95% CI=48-167

90 o=2.05, 95% CI=1.5, 2.8) and lifetime users (odds ratio=1.94, 95% CI=1.29, 2.93).

91 likely to require renal replacement therapy (odds ratio, 10.4; 95% CI, 5.9-18.1), suffer prolonged ho

92 ntravitreal injections (AMD and PCV adjusted odds ratio, 12.1 [P = 0.001] and 12.5 [P = 0.004] for >=

93 oponin was high basal inferolateral wall T2 (odds ratio, 18.2 [95% CI, 3.7-90.9], P<0.0001).

94 ion Aspiration Scale score >= 6) (p = 0.016; odds ratio = 2.17; 95% CI 1.14-4.13) and with risk of de

95 dependent risk factor for death in COVID-19 (odds ratio = 2.2; P = .03) and is associated with a long

96 Higher injury grade (adjusted odds ratio, 2.0 per one-grade increase [95% confidence i

97 graphy findings compared with standard care (odds ratio, 2.07; 95% confidence interval, 0.98-4.40; P

98 pendently associated with improved survival (odds ratio, 2.09 [95% CI, 1.42-3.09], P<0.001), contrary

99 gap was associated with increased mortality (odds ratio, 2.22; 95% CI, 1.30-3.82; p = 0.004) in patie

100 have not been associated with human disease (odds ratio, 2.22; 95% CI, 1.41 to 3.34), findings that d

101 h significantly increased risk of cirrhosis (odds ratio, 2.26; P < .001) and related comorbidities co

102 m antibiotics within 1 hour (44.6% vs 57.3%; odds ratio, 2.27; 95% CI, 1.34-3.86) and 3 hours (7.6% v

103 th an increased risk of the primary outcome: odds ratio, 2.28 (95% CI, 2.03-2.57; p < 0.001).

104 The risk of severe RSV-ALRI (odds ratio, 2.2; 95% confidence interval [CI], 1.6-2.8),

105 use (difference, 17.9% [95% CI, 6.3%-29.5%]; odds ratio, 2.31 [95% CI, 1.32-4.04]; P = .003).

106 d Acute Physiology Score II, with mortality (odds ratio, 2.31; 1.83-2.92).

107 ions on extracorporeal membrane oxygenation (odds ratio, 2.346; 95% CI, 1.203-4.572; p = 0.012) as si

108 xtracorporeal membrane oxygenation patients (odds ratio, 2.35; 95% CI, 1.87-2.96; p < 0.0001) were an

109 ), and admission after a same-day procedure (odds ratio, 2.82; 95% CI, 2.46-3.23 compared with emerge

110 6.41 [95% CI, 2.95-15.56]) and hypertension (odds ratio, 2.86 [95% CI, 1.39-6.17]) were found in indi

111 variation between hospitals (adjusted median odds ratio, 2.92 [95% CI, 2.77-3.10]).

112 I=1.68, 4.74) compared with past-year users (odds ratio=2.05, 95% CI=1.5, 2.8) and lifetime users (od

113 lence was higher for persistent heavy users (odds ratio=2.81, 95% CI=1.68, 4.74) compared with past-y

114 dence interval, 1.2-143; SMARCE1: P = 0.001; odds ratio, 2047; 95% confidence interval, 52-4.5e15, re

115 sophagus was an independent predictor of EI (odds ratio, 21.2; 95% CI: 6.23-72.0; P < 0.001).

116 nfidence interval, 1.5-30.6; MLH1: P = 0.04; odds ratio, 25.4; 95% confidence interval, 1.2-143; SMAR

117 esults in the RT arm and 42% in the LBT arm (odds ratio, 28.72; 95% confidence interval, 10.27-80.31)

118 ntly associated with current mania (adjusted odds ratio 3.49, 95% confidence interval (CI) 2.24-5.45,

119 7 strongly predicted high 90-day morbidity (odds ratio 3.96 per 10 CCI points, P < 0.001).

120 Mechanical ventilation (odds ratio, 3.25; 95% CI, 2.52-4.19; p < 0.01) and vasop

121 medical) patient (adjusted odds ratio, 3.29; 95% CI, 2.72-3.97).

122 d in FPIES triggered by cow's milk (adjusted odds ratio, 3.41; 95% CI, 1.21-9.63; P = .02) and banana

123 xtracorporeal cardiopulmonary resuscitation (odds ratio, 3.674; 95% CI, 1.425-9.473; overall p = 0.02

124 ly associated with an increased risk for UC (odds ratio, 3.7 [P = .004] and 4.6 [P = .001], respectiv

125 e VA of 20 logMAR letters or fewer (adjusted odds ratio, 3.8 and 10.6 for AMD and PCV, respectively).

126 nical ventilation (22.8% vs. 11.9%; adjusted odds ratio: 3.64; 95% confidence interval: 2.56 to 5.16;

127 ous abortion (N=1,289, k=3, prevalence=8.1%; odds ratio=3.77, 95% CI=1.15-12.39; NNH=15, 95% CI=8-111

128 ing odds of respiratory failure with sC5b-9 (odds ratio 31.9, 95% CI 1.4 to 746, P = 0.03) and need f

129 either Europe (odds ratio, 6.1) or New York (odds ratio, 32.9).

130 en after adjusting for deprivation (adjusted odds ratio 4.0 95% confidence interval, 1.7-10.6).

131 cluded presence of AF during echocardiogram (odds ratio, 4.22 [95% CI, 1.71-10.4], P=0.002), coronary

132 % CI, 1.34-3.86) and 3 hours (7.6% vs 24.5%; odds ratio, 4.31; 95% CI, 2.01-10.28) of sepsis diagnosi

133 redicted pulmonary dysfunction at discharge (odds ratio, 4.38; 95% CI, 1.66-11.56).

134 , 5.9-18.1), suffer prolonged hospital stay (odds ratio, 4.4; 95% CI, 3.0-6.4), and die in hospital (

135 in children less than 3 years old (adjusted odds ratio, 4.55; 95% CI, 3.1-6.6).

136 n 2017 compared to 12% in preceding 3 years (odds ratio, 4.84, P < .01).

137 rriers had LSMs of 7.1 kPa or more (adjusted odds ratio, 4.8; 95% confidence interval, 2.0-11.8).

138 predictor of HGD/IC in those remote lesions (odds ratio: 4.41, P = 0.039).

139 the strongest predictor of good compliance (odds ratio=4.13, 95% confidential interval= 3.60-4.75, p

140 r independently associated with EAD was MaS (odds ratio, 5.44; confidence interval, 1.05-28.21; P = 0

141 tly associated with travel to either Europe (odds ratio, 6.1) or New York (odds ratio, 32.9).

142 he association with AF was more significant (odds ratio, 6.15, P=3.26x10(-14)) when restricting to LO

143 and increased risks for overweight/obesity (odds ratio, 6.41 [95% CI, 2.95-15.56]) and hypertension

144 4.4; 95% CI, 3.0-6.4), and die in hospital (odds ratio, 6.4; 95% CI, 2.8-14.0) (p < 0.001 for all).

145 CI, 1.21-9.63; P = .02) and banana (adjusted odds ratio, 7.63; 95% CI, 2.10-27.80; P = .002).

146 ections were associated with strain sharing (odds ratio 8.50; 95% confidence interval 2.2 - 33.4, P =

147 cies in noncancer controls (PALB2: P = 0.02; odds ratio, 8.9; 95% confidence interval, 1.5-30.6; MLH1

148 entile, 0.50 (0.32-0.78); TRI versus no BAS, odds ratio (95% CI) range: first quartile, 0.15 (0.06-0.

149 ross all risk strata: VCD+BIV versus no BAS, odds ratio (95% CI) range: first quartile, 0.36 (0.18-0.

150 Adjusted odds ratios (95% CI; p-value) for infant deaths were sig

151 ated with higher rhinitis severity (adjusted odds ratio [95% CI] for a 10 mug/m(3) increase in PM(10)

152 positively associated with KC with adjusted odds ratios (adjusted OR 8.69, 95% CI 3.74-20.19; 6.23,

153 teristic curve (AUC) analysis and diagnostic odds ratios against both reference standards.

154 Voxelwise odds ratio and lesion-symptom maps demonstrated that CBH

155 on models were used to calculate lung cancer odds ratios and 95% confidence intervals (CIs) associate

156 stic regression models were used to estimate odds ratios and 95% confidence intervals.

157 Adjusted odds ratios (aOR)(95% CI) among participants with PVL >=

158 with no physical activity (K6 5-12: adjusted odds ratio [AOR] 0.86, 95% confidence interval [95%CI] 0

159 th female sex in the index patient (adjusted odds ratio [aOR] 1.56 [95% CI 1.38-1.77], p<0.0001) and

160 ience of physical (couples' UBL arm adjusted odds ratio [AOR] = 1.00, 95% confidence interval [CI]: 0

161 le CT = 56% vs favorable CTP = 57%, adjusted odds ratio [aOR] = 1.91, 95% confidence interval [CI] =

162 ree surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86).

163 abnormal interpretation rate (AIR) (adjusted odds ratio [AOR], 0.85; P < .001), which remained reduce

164 mortality was lower in the Midwest (adjusted odds ratio [aOR], 0.96 [95% CI, 0.93-0.98]; P<0.001) and

165 ith preoperative arterial diameter (adjusted odds ratio [aOR], 1.50 per 1-mm increase; 95% confidence

166 associated with preterm birth (age-adjusted odds ratio [aOR], 1.50; 95% confidence interval [CI], 1.

167 c testing as a PLD: age >=35 years (adjusted odds ratio [aOR], 1.75; 95% confidence interval [CI], 1.

168 of consensus anal hHSIL diagnosis (adjusted odds ratio [aOR], 10.34 [95% CI, 3.47-30.87]).

169 ntly associated with clinical cure (adjusted odds ratio [aOR], 2.63; 95% confidence interval [CI], 1.

170 tality, particularly for cirrhosis (adjusted odds ratio [aOR], 2.67; 95% confidence interval [95% CI]

171 es higher in women with anal hrHPV (adjusted odds ratio [aOR], 6.08 [95% confidence interval {CI}, 1.

172 ECRS with statistically significant adjusted odds ratios (aORs) after controlling for age, race, and

173 d random forest models to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CI) for

174 The age, site, and co-infection adjusted odds ratios (aORs) for moderate-to-severe diarrhoea asso

175 ysis requirement, AKI recovery, and adjusted odds ratios (aORs) with mortality.

176 ence (MD) for sensorimotor scores and common odds ratio (cOR) for AIS grade, with corresponding 95% C

177 ted for prespecified baseline variables, the odds ratio for 90-day mortality was 0.82 (95% CI, 0.68 t

178 independent predictor of symptomatic status (odds ratio for each 10-ms decrease in EMW: 1.37; 95% con

179 By using an MV score (0 to 6), the odds ratio for occlusion for a score above 3 was 16.3 (9

180 tatus, and self-rated general health status, odds ratios for 5-year progression ranged from 1.18 to 1

181 The odds ratios for success were significantly lower for Afr

182 Adjusted odds ratios for vaccination with 1, 2, and 3 doses were

183 The odds ratio in favor of resolution of severe asthma was 2

184 negatively associated with Pn-IST carriage (odds ratios, <1.0).

185 were associated with VRE infection (matched odds ratio [MOR], 16.72; 95% confidence interval [CI], 2

186 Unemployment (multivariable odds ratio [mOR], 2.9 [95% confidence interval {CI}, 1.3

187 iral therapy was associated with an adjusted odds ratio of 0.72 (95% confidence interval, .60-.88; P

188 A maximal EI of 1.27 was associated with an odds ratio of 16.16 (95% CI, 6.62-39.46) for PH-related

189 ontrols from large-scale population studies (odds ratio of 2.5, 95% confidence intervals of 1.4-4.4,

190 exhibit left ventricular remodeling with an odds ratio of 2.79 ([95% CI, 0.13-6.86]; P=0.026).

191 the index date, there was a slightly higher odds ratio of dementia in patients with the lowest use o

192 After adjusting for age, sex and race, odds ratio of inflammatory polyps in IBD patients was 6.

193 The estimated odds ratio of SARS-CoV-2 prevalence between the cancer c

194 Furthermore, the diagnostic odds ratio of YEARS was higher than Wells' score (6.27 v

195 currence, and distal adenoma recurrence with odds ratios of 4.32 (2.06-9.04 95% CI), 3.47 (1.67-7.22

196 The adjusted odds ratios of cardiopulmonary and noncardiopulmonary co

197 ssion (LR) was used to estimate the risk and odds ratios of mean Index score on two outcomes in the s

198 On multivariate regression (odds ratio or hazard ratio, 95% confidence interval), di

199 d with a higher prevalence of periodontitis (Odds ratio (OR) (highest vs. lowest quartile of FLI),1.6

200 e factor wound irrigation with polyhexanide [odds ratio (OR) 0.44; 95% confidence interval (CI) 0.27-

201 bally with no difference between study arms [odds ratio (OR) 0.96 (0.74-1.25)].

202 ently predictive of AKI were age [P = 0.027, odds ratio (OR) 1.02 (1.00-1.04)], male sex [P = 0.015,

203 SBO was associated with increased morbidity [odds ratio (OR) 1.2, P = 0.004], but not readmission (OR

204 rates (FLR <=30%: 32.1% vs FLR >30%: 28.6%; odds ratio (OR) 1.22, 95% CI 0.46-3.27) or major complic

205 n private patients to be referred to the ED [odds ratio (OR) 1.32, 95% confidence interval (CI) 1.09-

206 tients with parathyroid autotransplantation [Odds ratio (OR) 1.72; 95% confidence interval 1.47-2.01]

207 s was associated with decreased odds of LGA (odds ratio (OR) = 0.63, 95% confidence interval (CI): 0.

208 ar of life was not associated with ALL risk (odds ratio (OR) = 0.85, 95% confidence interval (CI): 0.

209 y was associated with increased odds of LBW [odds ratio (OR) = 1.40, 95% confidence interval (CI): 1.

210 The primary outcome was sNDI, with the odds ratio (OR) calculated.

211 The TH group showed a significantly higher odds ratio (OR) for DM in men aged 64 years or younger (

212 ble logistic regression model calculated the odds ratio (OR) for SCAD among patients with a history o

213 Data were pooled as odds ratio (OR) or mean difference (MD) with a random-ef

214 The odds ratio (OR) per interquartile range (IQR) increase [

215 ated with lower risk of small vessel stroke [odds ratio (OR) per standard deviation = 0.85, 95% confi

216 eloping colon pathology include tobacco use (odds ratio (OR), 2.0; 95% confidence interval (CI), 1.2-

217 The odds ratios (OR) of carrying a diagnosis of DED given th

218 Odds ratios (OR) with 95% confidence intervals (CI) for

219 stent activity at 3 months were male gender (odds ratio [OR] 0.54, 95% confidence interval [CI] 0.32-

220 p = 0.02) with increased risk of macrosomia (odds ratio [OR] 1.38, 95% CI 1.01-1.89, p = 0.04) versus

221 rom 528 [52.2%] to 624 [61.7%] individuals) (odds ratio [OR] 1.6, 95% CI 1.2-2.1; P = 0.001).

222 ssed individually using MR, LDL cholesterol (odds ratio [OR] 1.66 per 1-standard-deviation-higher tra

223 d with outcome: >=1+ anterior chamber cells (odds ratio [OR] 1.66, 95% confidence interval 1.09-2.52)

224 1 [32%] of 65 in the control group; adjusted odds ratio [OR] 1.74, 95% CI 0.81-3.74).

225 Frisen grade >=3 (odds ratio [OR] 10.21, P < .0053) and cases with worseni

226 or pathologic response were bevacizumab use (odds ratio [OR] 2.22; P = 0.001), tumor size <3 cm (OR 1

227 an non-industry, non-US Government sponsors (odds ratio [OR] 3.08 [95% CI 2.52-3.77]), and sponsors r

228 he standard GVHD prophylaxis group (adjusted odds ratio [OR] 3.49 [95% CI 1.60-7.60]; p=0.0016).

229 d during the previous round of MDA (adjusted odds ratio [OR] 3.60, 95% CI 3.08-4.20 for children and

230 yndrome made every day a challenge (adjusted odds ratio [OR] 3.81, 95% confidence interval [CI] 2.49

231 se by >=5 points from week 4 to 8 (P = .004, odds ratio [OR] 31.3, 95% confidence interval [CI] 3.0 t

232 ociated with having a diagnosis of melanoma (odds ratio [OR] 5.01; 95% Confidence Interval [CI] 3.50-

233 r likelihood of preparing dinner at home (Q4 odds ratio [OR] = 0.3 [95% CI 0.1-0.9]; P = 0.03) relati

234 increase in the PRSs for total cholesterol (odds ratio [OR] = 0.92; 95% confidence interval [CI] = 0

235 d increased risks of sensitization to birch (odds ratio [OR] = 1.12 [95% CI = 1.01-1.25] per 10-mug/m

236 oned variables indentified longer follow-up (odds ratio [OR] = 1.3 [95% confidence interval {CI} 1.1-

237 symptoms and arrival at the health facility (odds ratio [OR] = 1.33, 95% CI: 1.07-1.64 for a delay of

238 not have a lower rate of sICH (vs 0-3 days; odds ratio [OR] = 1.49, 95% confidence interval [CI] = 0

239 quintile compared with the middle quintile (odds ratio [OR] = 1.50, 95% confidence interval [CI] = 1

240 g for sociodemographic/medical history, BMI (Odds Ratio [OR] = 1.62 [95%CI 1.32-1.99]), waist-to-heig

241 itis in the final logistic model were: MetS (odds ratio [OR] = 2.02; P = 0.003), number of teeth <=14

242 roportion of pathogenic variants in the CFH (odds ratio [OR] = 2.88; P = 0.006), CFI (OR = 4.45; P =

243 n 2 years than men with normal genetic risk (odds ratio [OR] = 8.94, p < 0.01).

244 AD signature PiB SUVr (odds ratio [OR] [95% confidence interval (CI)] = 0.52 [0

245 er scores indicating a worse condition (with odds ratio [OR] greater than 1.00 favouring the control

246 onal outcome at 90 days (mRS = 0-2, adjusted odds ratio [OR] per 30 minutes increase in time = 0.91,

247 ls for classical hamartoma-related features (odds ratio [OR] range of 4.1-102.9).

248 received fewer eye examinations at 5 years (odds ratio [OR], 0.79; P < 0.01) than those with private

249 During follow-up, opioid injecting (odds ratio [OR], 0.95; 95% confidence interval [CI], 0.9

250 ated (multivariate analysis) with older age (odds ratio [OR], 1.09; 95% CI, 1.07-1.11; P < 0.001), Ru

251 h was associated with larger tumor diameter (odds ratio [OR], 1.15, 95% confidence interval [CI], 1.0

252 r glaucoma suspect designation (younger age: odds ratio [OR], 1.44; P = 0.037; and smaller cornea: OR

253 Global longitudinal strain (odds ratio [OR], 1.71; 95% CI, 1.11 to 2.63), chronotrop

254 with thromboembolic events were female sex (odds ratio [OR], 1.7; 95% confidence interval [CI]: 1.1,

255 noninvasive test (stress: 14.6% versus 8.5%, odds ratio [OR], 1.91; CTA: 36.5% versus 8.4%, OR, 5.95;

256 fied at 6p21.32 (rs35406322) (P=3.29x10(-8); odds ratio [OR], 1.93; 95% confidence interval [95% CI],

257 d with antimalarial antibody levels to AMA1 (odds ratio [OR], 2.41, P < .001; OR, 2.07, P < .001) and

258 Recent stimulant injecting (odds ratio [OR], 2.48 [95% confidence interval {CI}, 1.2

259 of 63 [79%] versus 37 of 63 [59%] patients; odds ratio [OR], 2.7; 95% confidence interval [95% CI],

260 In multivariate analysis, FIB-4 >=2.67 (odds ratio [OR], 3.41; 95% confidence interval [CI], 1.3

261 cal and CT parameters, consolidation burden (odds ratio [OR], 3.4; 95% confidence interval [CI]: 1.7,

262 hich demonstrated neoplastic transformation (odds ratio [OR], 3.729; 95% confidence interval [CI], 1.

263 Asymptomatic children with diabetes (odds ratio [OR], 6.5; P = 0.01), a recent contact (OR, 2

264 fection included pre-existing renal disease (odds ratio [OR], 7.4; 95% CI, 2.5-22.0), oxygen requirem

265 However, after adjustment, medical mistrust (odds ratio [OR]: 0.59; 95% confidence interval [CI]: 0.3

266 .73 m(2) was 2.2% (20 of 889) for CT and US (odds ratio [OR]: 0.98; 95% confidence interval [CI]: 0.5

267 -term visual field recovery and maintenance (odds ratio [OR]: 1.26; 95% confidence interval [CI]: 1.1

268 multiple regression analysis, PKP (vs DALK) (odds ratio [OR]: 8.52; P = .009), worse preoperative UDV

269 to 39 years (for females, 19.8% versus 4.7% [odds ratio {OR} = 5.05; 95% confidence interval {CI} = 3

270 ealth with two home visits arm (33% vs. 45%, Odds Ratio(OR): 0.55, 95% CI: 0.31, 0.97) and the mHealt

271 igher rate of pain at rest [EHS I vs EHS II: odds ratio, OR = 1.350 (1.180-1.543), P < 0.001; EHS I v

272 Conditional logistic regression odds ratios (ORs) accounting for individual matching on

273 timate unadjusted and multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (95% CI).

274 Summary estimates were reported as odds ratios (ORs) and corresponding 95% confidence inter

275 and cardiovascular risk factors to estimate odds ratios (ORs) between 1-SD increments in HDL functio

276 Odds ratios (ORs) of disease were determined according t

277 The odds ratios (ORs) per 1-SD increase of log-transformed a

278 Logistic regression yielded adjusted odds ratios (ORs) per SD higher usual levels of log-tran

279 Odds ratios (ORs) were calculated as part of the logisti

280 Odds ratios (ORs) were calculated with 95% confidence in

281 tandardized detection rates and age-adjusted odds ratios (ORs) were calculated.

282 Individual survey odds ratios (ORs) were pooled using random-effects meta-

283 Odds ratios (ORs) with 95% confidence intervals (CIs) we

284 conditional logistic regression to calculate odds ratios (ORs).

285 ity and morbidity [e.g., circulatory deaths, odds ratio per 5 degrees C increase = 1.16 (95% CI: 1.03

286 ease [95% CI, 0.30-0.90], P=0.01), and LVEF (odds ratio, per 1% increase, 1.09 [95% CI, 1.02-1.16], P

287 ariant PRS was strongly associated with AAA (odds ratio(PRS), 1.26 [95% CI, 1.18-1.36]; P(PRS)=2.7x10

288 of family history and smoking risk factors (odds ratio(PRS+family history+smoking), 1.24 [95% CI, 1.

289 r of adverse childhood experiences (adjusted odds ratio range=1.04-1.18) were significantly associate

290 sexual orientation discrimination (adjusted odds ratio range=1.08-1.10), number of stressful life ev

291 ), number of stressful life events (adjusted odds ratio range=1.25-1.43), and number of adverse child

292 ) database, and by calculating the reporting odds ratios (ROR) with 95% confidence intervals.

293 The mortality odds ratio was 0.84 (CI 0.65-0.96).

294 highest 5% of the PRS to the lowest 95%, CAD odds ratio was 1.36 (95% CI, 1.24-1.49) for the LDL-C PR

295 Using an optimistic prior, posterior median odds ratios were 0.61 (95% credible interval, 0.41-0.90)

296 The pooled odds ratios were 2.15 (95% CI=1.58, 2.94) and 2.02 (95%

297 Odds ratios were estimated using conditional logistic re

298 Adjusted odds ratios were higher among participants without aller

299 severity of rhinitis, with similar adjusted odds ratios whatever the level of severity.

300 come of inpatient admissions, representative odds ratios (with 95% CIs) for death within 6 months of